Jeffrey D Edwards1, Carolyn T Herzig2, Hangsheng Liu3, Monika Pogorzelska-Maziarz4, Philip Zachariah5, Andrew W Dick3, Lisa Saiman6, Patricia W Stone2, E Yoko Furuya7. 1. Division of Pediatric Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY. Electronic address: jde2134@columbia.edu. 2. Center for Health Policy, Columbia University School of Nursing, New York, NY. 3. RAND Corporation, Boston, MA. 4. Jefferson School of Nursing, Thomas Jefferson University, Philadelphia, PA. 5. Division of Pediatric Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY. 6. Division of Pediatric Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY; Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, NY. 7. Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, NY; Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY.
Abstract
BACKGROUND: Knowing the temporal trend central line-associated bloodstream infection (CLABSI) rates among U.S. pediatric intensive care units (PICUs), the current extent of central line bundle compliance, and the impact of compliance on rates is necessary to understand what has been accomplished and can be improved in CLABSI prevention. METHODS: This is a longitudinal study of PICUs in National Healthcare Safety Network hospitals and a cross-sectional survey of directors and managers of infection prevention and control departments regarding PICU CLABSI prevention practices, including self-reported compliance with elements of central line bundles. Associations between 2011-2012 PICU CLABSI rates and infection prevention practices were examined. RESULTS: Reported CLABSI rates decreased during the study period, from 5.8 per 1,000 line days in 2006 to 1.4 in 2011-2012 (P < .001). Although 73% of PICUs had policies for all central line prevention practices, only 35% of those with policies reported ≥95% compliance. PICUs with ≥95% compliance with central line infection prevention policies had lower reported CLABSI rates, but this association was statistically insignificant. CONCLUSION: There was a nonsignificant trend in decreasing CLABSI rates as PICUs improved bundle policy compliance. Given that few PICUs reported full compliance with these policies, PICUs increasing their efforts to comply with these policies may help reduce CLABSI rates.
BACKGROUND: Knowing the temporal trend central line-associated bloodstream infection (CLABSI) rates among U.S. pediatric intensive care units (PICUs), the current extent of central line bundle compliance, and the impact of compliance on rates is necessary to understand what has been accomplished and can be improved in CLABSI prevention. METHODS: This is a longitudinal study of PICUs in National Healthcare Safety Network hospitals and a cross-sectional survey of directors and managers of infection prevention and control departments regarding PICU CLABSI prevention practices, including self-reported compliance with elements of central line bundles. Associations between 2011-2012 PICU CLABSI rates and infection prevention practices were examined. RESULTS: Reported CLABSI rates decreased during the study period, from 5.8 per 1,000 line days in 2006 to 1.4 in 2011-2012 (P < .001). Although 73% of PICUs had policies for all central line prevention practices, only 35% of those with policies reported ≥95% compliance. PICUs with ≥95% compliance with central line infection prevention policies had lower reported CLABSI rates, but this association was statistically insignificant. CONCLUSION: There was a nonsignificant trend in decreasing CLABSI rates as PICUs improved bundle policy compliance. Given that few PICUs reported full compliance with these policies, PICUs increasing their efforts to comply with these policies may help reduce CLABSI rates.
Authors: Marlene R Miller; Matthew F Niedner; W Charles Huskins; Elizabeth Colantuoni; Gayane Yenokyan; Michele Moss; Tom B Rice; Debra Ridling; Deborah Campbell; Richard J Brilli Journal: Pediatrics Date: 2011-10-24 Impact factor: 7.124
Authors: Derek S Wheeler; Mary Jo Giaccone; Nancy Hutchinson; Mary Haygood; Pattie Bondurant; Kathy Demmel; Uma R Kotagal; Beverly Connelly; Melinda S Corcoran; Kristin Line; Kate Rich; Pamela J Schoettker; Richard J Brilli Journal: Pediatrics Date: 2011-09-19 Impact factor: 7.124
Authors: Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel Journal: N Engl J Med Date: 2006-12-28 Impact factor: 91.245
Authors: Marlene R Miller; Michael Griswold; J Mitchell Harris; Gayane Yenokyan; W Charles Huskins; Michele Moss; Tom B Rice; Debra Ridling; Deborah Campbell; Peter Margolis; Stephen Muething; Richard J Brilli Journal: Pediatrics Date: 2010-01-11 Impact factor: 7.124
Authors: Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint Journal: Clin Infect Dis Date: 2011-05 Impact factor: 9.079
Authors: Matthew F Niedner; W Charles Huskins; Elizabeth Colantuoni; John Muschelli; J Mitchell Harris; Tom B Rice; Richard J Brilli; Marlene R Miller Journal: Infect Control Hosp Epidemiol Date: 2011-10-13 Impact factor: 3.254
Authors: R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo Journal: Public Health Rep Date: 2007 Mar-Apr Impact factor: 2.792
Authors: Jeffrey E Nowak; Richard J Brilli; Michael R Lake; Karen W Sparling; John Butcher; Marion Schulte; Derek S Wheeler Journal: Pediatr Crit Care Med Date: 2010-09 Impact factor: 3.624
Authors: E Yoko Furuya; Andrew Dick; Eli N Perencevich; Monika Pogorzelska; Donald Goldmann; Patricia W Stone Journal: PLoS One Date: 2011-01-18 Impact factor: 3.240